Immune checkpoint inhibitors in the treatment of glioblastoma multiforme

Adrianna Winnicka

doi:10.18778/1730-2366.18.05

Immune checkpoint inhibitors in the treatment of glioblastoma multiforme

Authors

Adrianna Winnicka University of Lodz, Faculty of Biology and Environmental Protection, Poland https://orcid.org/0009-0003-9596-9892

DOI:

https://doi.org/10.18778/1730-2366.18.05

Keywords:

glioblastoma multiforme, immunotherapy, immune checkpoint inhibitors, monoclonal antibodies, neurooncology

Downloads

Download data is not yet available.

References

Yasinjan, F., Xing, Y., Geng, H., Guo, R., Yang, L., Liu, Z., Wang, H. 2023. Immunotherapy: a promising approach for glioma treatment. Frontiers in Immunology, 14, 1255611.
Google Scholar

Linares, C.A., Varghese, A., Ghose, A., Shide, S.D., Adeleke, S., Sanchez, E., Sheriff, M., Chargari, C., Rassy, E., Boussios, S. 2023. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. International Journal of Molecular Sciences, 24(17), 13215.
Google Scholar

Downloads

Published

2024-09-18

How to Cite

Winnicka, A. (2024). Immune checkpoint inhibitors in the treatment of glioblastoma multiforme. Acta Universitatis Lodziensis. Folia Biologica Et Oecologica, 18, 13–13. https://doi.org/10.18778/1730-2366.18.05